Metabolic Technologies
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Metabolic Technologies sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).
Metabolic Technologies: 16 sponsored US clinical trials, none currently recruiting.
Metabolic Technologies sponsors 16 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 15 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Men and Women, with 1 trials.
Top-decile sponsor footprint
Metabolic Technologies ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
16 total, page 1 of 1
2-HOBA: Multiple Dosing Study in Healthy Humans
NCT03555682
2-HOBA: Multiple Dosing Study in Older Adults
NCT03556319
Brain Penetrance of 2-HOBA in Humans
NCT03554096
2-HOBA: Initial Evaluation in Humans
NCT03176940
The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism
NCT02717013
Effects of HMB Supplementation on Recovery Following ACL Surgery
NCT02602561
Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2
NCT02043171
The Effects of β-Hydroxy-β-methylbutyrate Free Acid and High-Intensity Interval Training
NCT01941368
Study to Examine the Effects of ATP Supplementation on Muscle Excitability and Reaction Time During and Following a Repeated Sprint Bout
NCT02093611
Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses
NCT01914952
Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness
NCT01793779
Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids
NCT01643265
The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes
NCT01508338
Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate
NCT01150526
Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle Performance
NCT01141504
Nutritional Intervention for Age-related Muscular Function and Strength Losses
NCT00874575
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
Therapeutic Areas
How the Metabolic Technologies early-phase archive is shaped
16 indexed studies, none listed as recruiting (0% open); 15 completed (94%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Healthy Men and Women (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Metabolic Technologies: archived-pipeline peers nationwide
Peers matched on 16 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Metabolic Technologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 16 archived trials
- Accelerated Community Oncology Research Network · 16 trials · 0% recruiting
- Altimmune · 16 trials · 6% recruiting
- American University · 16 trials · 13% recruiting
- Anthera Pharmaceuticals · 16 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Metabolic Technologies page
16 registered trials is a research-attention snapshot, not an endorsement of Metabolic Technologies or any single study.
- None of Metabolic Technologies's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy Men and Women is the condition Metabolic Technologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Men and Women trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Metabolic Technologies pipeline card: 16 registered trials from official public datasets.Report a data error.